Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...
主要な著者: | Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A |
---|---|
フォーマット: | Journal article |
出版事項: |
Nature Publishing Group
2017
|
類似資料
-
Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity
著者:: Chauveau, L, 等
出版事項: (2021) -
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
著者:: Jerri C. Caldeira, 等
出版事項: (2020-04-01) -
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
著者:: Schneider, J, 等
出版事項: (1998) -
Virus-like particles as vaccine adjuvants.
著者:: Gilbert, S
出版事項: (2001) -
Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
著者:: Dégano, P, 等
出版事項: (1999)